Phase I/IIa European trial of Tribetarna in patients with drug-resistant non-small cell lung cancer.
Phase of Trial: Phase I/II
Latest Information Update: 08 Jul 2013
Price : $35 *
At a glance
- Drugs Tribetarna (Primary)
- Indications Non-small cell lung cancer
- Focus Adverse reactions
- 08 Jul 2013 Planned initiation date changed to 1 Dec 2014.
- 27 Jun 2013 New trial record
- 03 Jun 2013 This trial is planned to commence in the fourth quarter of 2014, according to a Benitec Biopharma media release.